Wojcicki, A.V.; Kadapakkam, M.; Frymoyer, A.; Lacayo, N.; Chae, H.-D.; Sakamoto, K.M.
Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit? Cancers 2020, 12, 441.
https://doi.org/10.3390/cancers12020441
AMA Style
Wojcicki AV, Kadapakkam M, Frymoyer A, Lacayo N, Chae H-D, Sakamoto KM.
Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit? Cancers. 2020; 12(2):441.
https://doi.org/10.3390/cancers12020441
Chicago/Turabian Style
Wojcicki, Anna V., Meena Kadapakkam, Adam Frymoyer, Norman Lacayo, Hee-Don Chae, and Kathleen M. Sakamoto.
2020. "Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit?" Cancers 12, no. 2: 441.
https://doi.org/10.3390/cancers12020441
APA Style
Wojcicki, A. V., Kadapakkam, M., Frymoyer, A., Lacayo, N., Chae, H.-D., & Sakamoto, K. M.
(2020). Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit? Cancers, 12(2), 441.
https://doi.org/10.3390/cancers12020441